Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

@article{Dondorp2005ArtesunateVQ,
  title={Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial},
  author={Arjen M. Dondorp and François Nosten and Kasia Stepniewska and Nicholas Day and Nick White},
  journal={The Lancet},
  year={2005},
  volume={366},
  pages={717-725}
}

Figures and Tables from this paper

Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.

Artesunate is more effective than quinine, in term of parasite and fever clearance time, in the treatment of P. falciparum malaria in eastern Sudan, and in comatose patients, there was no difference between the two groups in coma resolution time.

Artesunate Dosing in Severe Falciparum Malaria

A comparison of a once daily 4 mg/kg intravenous artesunate dose with the WHO-recommended regimen in African children hospitalized with malaria and the authors conclude that a simple 24-hour, 3-dose regimen should be further studied and developed to licensure for treating severe malaria in children are think that this conclusion is not valid and that it could be dangerous.

Artesunate Suppositories versus Intramuscular Artemether for Treatment of Severe Malaria in Children in Papua New Guinea

In severely ill children with malaria in PNG, artesunate suppositories were at least as effective as i.m. artemether and may, therefore, be useful in settings where parenteral therapy cannot be given.

A simplified intravenous artesunate regimen for severe malaria.

Pharmacodynamic analysis suggests that 3 doses of artesunate were not inferior to 5 doses for the treatment of severe malaria in children.

Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial

In this high transmission setting, adequate initial treatment outcomes are observed followed by very high rates of malaria re-infection post severe malaria treatment, which needs to be investigated and surveillance mechanisms for resistance markers established.

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria

Intramuscular artesunate may be superior to intramusclescular artemether for the treatment of severe malaria in adults with severe falciparum malaria.

Parenteral artesunate reduced inhospital mortality more than quinine in severe falciparum malaria

Patients were allocated to intravenous artesunate or quinine dihydrochloride, 20 mg/kg loading dose infused over 4 hours (in 500 ml of 5% dextrose water or 0.9% saline), and then 10mg/kg infused over 228 hours 3 times/day until oral quinines could be taken.

Artesunate versus quinine for treating severe malaria.

The evidence clearly supports the superiority of parenteral artesunate over quinine for the treatment of severe malaria in both adults and children and in different regions of the world.

Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre

IV AS is found to be safe and effective, with shorter LOS, faster parasite and fever clearance, no fatalities or hypoglycaemic events, and fewer ICU admissions versus IV Q, corroborates both developing world trials and smaller European case series.
...

References

SHOWING 1-10 OF 42 REFERENCES

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.

  • P. NewtonB. Angus N. White
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2003
A randomized, open-label comparison of artesunate and quinine was conducted in 113 adults with clinically severe falciparum malaria in western Thailand, and it was found that artes unate is at least as effective in the treatment of adults with severe malaria.

A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.

Artemether is a satisfactory alternative to quinine for the treatment of severe malaria in adults in Vietnam and is associated with a higher risk of hypoglycemia, but there were no other serious side effects in either group.

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria.

A trial of artemether or quinine in children with cerebral malaria.

Artemether is as effective as quinine in the treatment of cerebral malaria in children, and residual neurologic sequelae are detected in 576 Gambian children analyzed at approximately five months for neurologic disease.

Intramuscular Bioavailability and Clinical Efficacy of Artesunate in Gabonese Children with Severe Malaria

The pharmacokinetics and bioavailability of ARS given by the intramuscular route support the use of i.m. ARS in children with severe malaria.

Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria.

A total of 141 cases of strictly defined cerebral malaria were studied in a controlled trial of three regimens: (1) intramuscular artemether plus oral mefloquine, (2) intravenous artesunate plus oral

Artemether Bioavailability after Oral or Intramuscular Administration in Uncomplicated Falciparum Malaria

ABSTRACT The antimalarial activity of artemether following oral or intramuscular administration in the plasma of 15 adults with acute uncomplicated Plasmodium falciparum malaria was measured by